Rates of serious infection, including site‐specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy … WG Dixon, K Watson, M Lunt, KL Hyrich, AJ Silman, DPM Symmons Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 842 | 2006 |
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR) WG Dixon, KL Hyrich, KD Watson, M Lunt, J Galloway, A Ustianowski, ... Annals of the rheumatic diseases 69 (3), 522-528, 2010 | 719 | 2010 |
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results … JB Galloway, KL Hyrich, LK Mercer, WG Dixon, B Fu, AP Ustianowski, ... Rheumatology 50 (1), 124-131, 2011 | 627 | 2011 |
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: results from the British Society … WG Dixon, KD Watson, M Lunt, KL Hyrich, AJ Silman, DPM Symmons Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 621 | 2007 |
Serious infection following anti–tumor necrosis factor α therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies WG Dixon, DPM Symmons, M Lunt, KD Watson, KL Hyrich, AJ Silman Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 333 | 2007 |
Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics … MJ Harrison, WG Dixon, KD Watson, Y King, R Groves, KL Hyrich, ... Annals of the rheumatic diseases 68 (2), 209-215, 2009 | 251 | 2009 |
Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysis WG Dixon, M Abrahamowicz, ME Beauchamp, DW Ray, S Bernatsky, ... Annals of the rheumatic diseases 71 (7), 1128-1133, 2012 | 239 | 2012 |
Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for … WG Dixon, KD Watson, M Lunt, LK Mercer, ... Arthritis care & research 62 (6), 755-763, 2010 | 211 | 2010 |
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology … WG Dixon, KL Hyrich, KD Watson, M Lunt, DPM Symmons, ... Annals of the rheumatic diseases 69 (6), 1086-1091, 2010 | 187 | 2010 |
Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register JB Galloway, KL Hyrich, LK Mercer, WG Dixon, AP Ustianowski, M Helbert, ... Annals of the rheumatic diseases 70 (10), 1810-1814, 2011 | 184 | 2011 |
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an … C Strehl, JWJ Bijlsma, M de Wit, M Boers, N Caeyers, M Cutolo, ... Annals of the rheumatic diseases 75 (6), 952-957, 2016 | 177 | 2016 |
A comparison of patient characteristics and outcomes in selected European and US rheumatoid arthritis registries JR Curtis, A Jain, J Askling, SL Bridges Jr, L Carmona, W Dixon, A Finckh, ... Seminars in arthritis and rheumatism 40 (1), 2-14. e1, 2010 | 174 | 2010 |
Genome-wide association analysis identifies novel loci for chronotype in 100,420 individuals from the UK Biobank JM Lane, I Vlasac, SG Anderson, SD Kyle, WG Dixon, DA Bechtold, S Gill, ... Nature communications 7 (1), 1-10, 2016 | 169 | 2016 |
European biologicals registers: methodology, selected results and perspectives A Zink, J Askling, WG Dixon, L Klareskog, AJ Silman, DPM Symmons Annals of the rheumatic diseases 68 (8), 1240-1246, 2009 | 163 | 2009 |
Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology … JB Galloway, LK Mercer, A Moseley, WG Dixon, AP Ustianowski, ... Annals of the rheumatic diseases 72 (2), 229-234, 2013 | 162 | 2013 |
What effects might anti-TNFα treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFα in cardiovascular … WG Dixon, DPM Symmons Annals of the rheumatic diseases 66 (9), 1132-1136, 2007 | 153 | 2007 |
The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses WG Dixon, S Suissa, M Hudson Arthritis research & therapy 13 (4), R139, 2011 | 151 | 2011 |
Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative A Baillet, L Gossec, L Carmona, M de Wit, Y van Eijk-Hustings, ... Annals of the rheumatic diseases 75 (6), 965-973, 2016 | 144 | 2016 |
Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis LK Mercer, M Lunt, ALS Low, WG Dixon, KD Watson, DPM Symmons, ... Annals of the rheumatic diseases 74 (6), 1087-1093, 2015 | 137 | 2015 |
Low grip strength is associated with bone mineral density and vertebral fracture in women WG Dixon, M Lunt, SR Pye, J Reeve, D Felsenberg, AJ Silman, TW O'neill Rheumatology 44 (5), 642-646, 2005 | 131 | 2005 |